Compare ATYR & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATYR | QUCY |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | Germany |
| Employees | 58 | 13 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.1M | 40.1M |
| IPO Year | N/A | 2021 |
| Metric | ATYR | QUCY |
|---|---|---|
| Price | $0.54 | $1.50 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $3.67 | N/A |
| AVG Volume (30 Days) | 2.0M | ★ 3.2M |
| Earning Date | 05-01-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.34 |
| Revenue Next Year | N/A | $171.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $0.30 |
| 52 Week High | $7.29 | $4.93 |
| Indicator | ATYR | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 50.61 | 39.84 |
| Support Level | $0.42 | $0.38 |
| Resistance Level | $0.59 | $2.36 |
| Average True Range (ATR) | 0.04 | 0.25 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 75.87 | 0.52 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.